TSHA logo

Taysha Gene Therapies (TSHA) CAPEX

annual CAPEX:

$374.00K-$7.00M(-94.92%)
December 31, 2024

Summary

  • As of today (June 22, 2025), TSHA annual capital expenditures is $374.00 thousand, with the most recent change of -$7.00 million (-94.92%) on December 31, 2024.
  • TSHA annual CAPEX is now -98.50% below its all-time high of $24.87 million, reached on December 31, 2022.

Performance

TSHA CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTSHAcash flow metrics

quarterly CAPEX:

$378.00K+$380.00K(+19000.00%)
March 31, 2025

Summary

  • As of today (June 22, 2025), TSHA quarterly capital expenditures is $378.00 thousand, with the most recent change of +$380.00 thousand (+19000.00%) on March 31, 2025.
  • Over the past year, TSHA quarterly CAPEX has increased by +$238.00 thousand (+170.00%).
  • TSHA quarterly CAPEX is now -90.31% below its all-time high of $3.90 million, reached on March 31, 2023.

Performance

TSHA quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTSHAcash flow metrics

TTM CAPEX:

$612.00K+$238.00K(+63.64%)
March 31, 2025

Summary

  • As of today (June 22, 2025), TSHA TTM capital expenditures is $612.00 thousand, with the most recent change of +$238.00 thousand (+63.64%) on March 31, 2025.
  • Over the past year, TSHA TTM CAPEX has dropped by -$3.00 million (-83.04%).
  • TSHA TTM CAPEX is now -93.67% below its all-time high of $9.66 million, reached on September 30, 2023.

Performance

TSHA TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTSHAcash flow metrics

TSHA CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-94.9%+170.0%-83.0%
3 y3 years---
5 y5 years---

TSHA CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-98.5%at low-90.3%+887.5%-93.7%+63.6%
5 y5-year-98.5%at low-90.3%+887.5%-93.7%+63.6%
alltimeall time-98.5%at low-90.3%+887.5%-93.7%+63.6%

TSHA CAPEX History

DateAnnualQuarterlyTTM
Mar 2025
-
$378.00K(<-9900.0%)
$612.00K(+63.6%)
Dec 2024
$374.00K(-94.9%)
-$2000.00(-105.7%)
$374.00K(-4.8%)
Sep 2024
-
$35.00K(-82.6%)
$393.00K(-89.8%)
Jun 2024
-
$201.00K(+43.6%)
$3.86M(+6.9%)
Mar 2024
-
$140.00K(+723.5%)
$3.61M(-51.0%)
DateAnnualQuarterlyTTM
Dec 2023
$7.37M(-70.4%)
$17.00K(-99.5%)
$7.37M(-23.7%)
Sep 2023
-
$3.50M(-7391.7%)
$9.66M(+56.8%)
Jun 2023
-
-$48.00K(-101.2%)
$6.16M(-0.8%)
Mar 2023
-
$3.90M(+68.9%)
$6.21M(+168.9%)
Dec 2022
$24.87M
$2.31M
$2.31M

FAQ

  • What is Taysha Gene Therapies annual capital expenditures?
  • What is the all time high annual CAPEX for Taysha Gene Therapies?
  • What is Taysha Gene Therapies annual CAPEX year-on-year change?
  • What is Taysha Gene Therapies quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Taysha Gene Therapies?
  • What is Taysha Gene Therapies quarterly CAPEX year-on-year change?
  • What is Taysha Gene Therapies TTM capital expenditures?
  • What is the all time high TTM CAPEX for Taysha Gene Therapies?
  • What is Taysha Gene Therapies TTM CAPEX year-on-year change?

What is Taysha Gene Therapies annual capital expenditures?

The current annual CAPEX of TSHA is $374.00K

What is the all time high annual CAPEX for Taysha Gene Therapies?

Taysha Gene Therapies all-time high annual capital expenditures is $24.87M

What is Taysha Gene Therapies annual CAPEX year-on-year change?

Over the past year, TSHA annual capital expenditures has changed by -$7.00M (-94.92%)

What is Taysha Gene Therapies quarterly capital expenditures?

The current quarterly CAPEX of TSHA is $378.00K

What is the all time high quarterly CAPEX for Taysha Gene Therapies?

Taysha Gene Therapies all-time high quarterly capital expenditures is $3.90M

What is Taysha Gene Therapies quarterly CAPEX year-on-year change?

Over the past year, TSHA quarterly capital expenditures has changed by +$238.00K (+170.00%)

What is Taysha Gene Therapies TTM capital expenditures?

The current TTM CAPEX of TSHA is $612.00K

What is the all time high TTM CAPEX for Taysha Gene Therapies?

Taysha Gene Therapies all-time high TTM capital expenditures is $9.66M

What is Taysha Gene Therapies TTM CAPEX year-on-year change?

Over the past year, TSHA TTM capital expenditures has changed by -$3.00M (-83.04%)
On this page